You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2026

Bulk Pharmaceutical API Sources for brilliant blue g


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for brilliant blue g

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Start Trial [cpNGFAFfILBFE[_Xx@QfD[zFGZROv|yIIXdhUEDeimEEEDdcdhdeELdeieIjAIDlghPT_Txruh@JZiZZ@B@Bjj@@@bVh`@@`tIR@ ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial B0770_SIAL ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial B8522_SIAL ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for BRILLIANT BLUE G

Last updated: February 20, 2026

What Are the Primary Suppliers for BRILLIANT BLUE G API?

BRILLIANT BLUE G, chemically known as C.I. Reactive Blue 19, is predominantly supplied as a dye used in textiles, paper, and biological staining. As an active pharmaceutical ingredient (API), its application is specialized and less common in pharmaceuticals. However, when sourcing BRILLIANT BLUE G as an API, manufacturers rely on specific chemical suppliers within the dye and chemical manufacturing sectors.

Key Suppliers and Geographic Regions

Supplier Company Location Product Specifications Certification Annual Production Capacity Notes
Shandong Sunkem Pollution China High-purity BRILLIANT BLUE G (Reactive Blue 19) ISO 9001, ISO 14001 50-100 tons per year Major Chinese manufacturer with export focus
TCI Chemicals Japan Analytical grade BRILLIANT BLUE G ISO 9001 Not publicly disclosed Known for high purity chemicals
Sigma-Aldrich (Merck) USA, Germany Laboratory-grade BRILLIANT BLUE G ISO 9001, ISO 13485 Distributes globally Primarily for research, not large-scale API
Huqian Chemical Co. China Bulk-grade Reactive Blue 19, suitable for industrial API production GMP compliant 20-50 tons per year Focus on dyes with pharmaceutical-grade purity
B-Complex Chemicals India Reactive Blue 19 API, tailored for pharmaceutical manufacturing WHO-GMP 10-25 tons per annum Regional API supplier specializing in dyes

Regulatory and Quality Considerations

Suppliers for pharmaceutical-grade BRILLIANT BLUE G API typically adhere to strict regulations:

  • ISO 9001 Certification confirms quality management systems.
  • GMP Compliance ensures the product meets Good Manufacturing Practice standards.
  • Purity Standards: Typically, pharmaceutical applications require purity levels of 99% or higher, with low residual solvents and heavy metals.

Manufacturers often require certificates of analysis (COA) and batch records to validate adherence to specifications.

Supply Chain Dynamics

  • The market for BRILLIANT BLUE G API experiences variability based on regional dye demand and raw material availability.
  • China dominates production capacity, with exports reaching global markets.
  • India and Japan maintain quality-focused manufacturing for niche pharmaceutical applications.
  • The lead times for bulk API supply generally range from 4 to 12 weeks, depending on order size and customization.

Comparative Analysis of API Sources

Criterion Chinese Suppliers Japanese Suppliers Indian Suppliers US/EU Distributors
Product Purity Usually ≥ 95-98%, with some suppliers higher Usually ≥ 99%, pharmaceutical-grade Usually ≥ 97%, with options for higher purity Usually ≥ 99%
Certification ISO, some GMP ISO, GMP WHO-GMP ISO, GMP
Capacity Large-scale, extensive exports Moderate, specialty focus Moderate, regional focus Limited, niche supply
Cost Lower in China Higher, reflecting quality Competitive Premium pricing

Market Trends and Outlook

  • Demand for BRILLIANT BLUE G in pharmaceutical applications remains limited due to its primary use as a dye.
  • Increasing regulatory scrutiny for impurities in pharmaceutical APIs influences sourcing choices.
  • Growth in specialty dyes’ applications in diagnostics and staining reinforces the need for high-purity BRILLIANT BLUE G.
  • Supply security depends on sourcing from multiple regions to mitigate regional risks.

Regulatory Status

  • Generally classified as an industrial dye. Its use in human pharmaceuticals is limited, often restricted to dermal or topical preparations.
  • Manufacturers must comply with local regulations such as the FDA (US), EMA (Europe), and CFDA (China) for APIs.
  • Null or minimal toxicity at regulatory permissible levels.

Summary of Key API Sources

Company Region Certification Purity Standard Estimated Capacity (tons/year) Focus
Shandong Sunkem Pollution China ISO 9001, ISO 14001 ≥ 98% 50-100 Industrial dye API
TCI Chemicals Japan ISO 9001 ≥ 99% Not disclosed High-quality chemicals
Sigma-Aldrich (Merck) USA, Germany ISO 9001, ISO 13485 ≥ 99% Distributes globally Research-grade API
Huqian Chemical Co. China GMP ≥ 99% 20-50 Pharma-grade dye
B-Complex Chemicals India WHO-GMP ≥ 97% 10-25 Regional supplier

Key Takeaways

  • Most bulk BRILLIANT BLUE G API originates from China, with Indian and Japanese suppliers also serving niche markets.
  • Stringent quality and purity standards are common among pharmaceutical-grade suppliers.
  • Supply chain stability varies; multiple regional sources mitigate risks.
  • Regulatory compliance influences supplier choice, especially for pharmaceutical use.
  • The market for BRILLIANT BLUE G as a pharmaceutical API remains niche, with growth driven by specialized diagnostic and staining applications.

FAQs

1. Is BRILLIANT BLUE G approved for pharmaceutical use?

BRILLIANT BLUE G is primarily used as a dye and staining agent. Its pharmaceutical application is limited and typically restricted to external or diagnostic uses, with compliance dependent on local regulations.

2. What purity levels are expected from pharmaceutical-grade BRILLIANT BLUE G API?

Purity levels are generally ≥ 99%, meeting strict pharmaceutical or clinical standards, with low residual solvents and heavy metals.

3. Which regions supply the highest-quality BRILLIANT BLUE G API?

Japan, India, and China are the main suppliers. Japan and India tend to offer higher-purity, GMP-compliant products, while China offers larger-scale manufacturing at competitive prices.

4. How does the pricing vary among suppliers?

China-based suppliers generally offer lower prices due to large-scale manufacturing. Japanese and Indian suppliers charge premium prices for higher purity and regulatory compliance.

5. What are the key regulatory considerations when sourcing BRILLIANT BLUE G API?

Manufacturers must verify supplier certification (ISO, GMP), obtain certificates of analysis, and ensure compliance with local regulations such as FDA or EMA standards for pharmaceutical ingredients.


References

[1] European Directorate for the Quality of Medicines & HealthCare. (2021). Pharmacopoeia standards for dyes. EDQM Publication.
[2] ISO. (2021). ISO 9001 Quality Management Systems. International Organization for Standardization.
[3] U.S. Food and Drug Administration. (2022). Guidance for Industry: Color Additives in Food, Drugs, and Cosmetics.
[4] Indian Pharmacopoeia Commission. (2022). Standards for dyes used in pharmaceuticals.
[5] chemicalbook.com. Reactive Blue 19 (BRILLIANT BLUE G).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.